Corrigendum to: Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway

• Correction of figures in the original article on Stattic sensitizing osteosarcoma cells to EGFR inhibitors. • The corrected Figure 2 shows gefitinib decreased migration and invasion of OS cells. • The corrected Figure 6 shows Stattic promoted the inhibitory effect of gefitinib on metastasis of OS cells. • The corrigendum ensures accuracy of data presentation for reproducibility.